Honegger, HRefine your research by the most used items
Author / Editor
- Roth, Arnaud (3)
- Borner, M M (2)
- Herrmann, R (2)
- Aapro, M S (1)
- Alberto, Pierre (1)
- Bernhard, Jacqueline Simone (1)
- Betticher, D C (1)
- Brauchli, Patrik Olivier (1)
- Castiglione, M (1)
- Cavalli, F (1)
Document type
Full text accessibility
Full text version
Subject
- Humans (3)
- Adult (2)
- Aged (2)
- Female (2)
- Male (2)
- Middle aged (2)
- Treatment outcome (2)
- Adenocarcinoma/drug therapy/mortality/secondary (1)
- Antimetabolites, antineoplastic/administration & dosage/adverse effects/therapeutic use (1)
- Antineoplastic agents, phytogenic/administration & dosage/adverse effects/therapeutic use (1)
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO) | Roth, Arnaud; Maibach, R; Martinelli, G; Fazio, N; ... Goldhirsch, A | 2000 |
|
|
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity | Borner, M M; Bernhard, Jacqueline Simone; Dietrich, D.; Popescu, R; ... Roth, Arnaud | 2005 |
|
|
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study | Betticher, D C; Hsu Schmitz, S-F; Totsch, Martin; Hansen, E; ... Ris, H-B | 2006 |
